Latest News & Features
Big Pharma
Teva has successfully defended two patents related to its blockbuster multiple sclerosis drug Copaxone (glatiramer acetate) at the English High Court. 22 May 2015
Americas
Gilead Sciences is facing a challenge to its attempt to obtain a patent for its hepatitis C drug Sovaldi in certain Asian, Latin American and European countries. 20 May 2015
Americas
Californian genetic analysis company Illumina has sued Ariosa Diagnostics for allegedly infringing a patent through its Harmony Prenatal Test. 19 May 2015
Americas
The US Court of Appeals for the Federal Circuit has vacated and remanded a case between Classen Immunotherapies and Elan Pharmaceuticals, to determine whether Elan infringed a Classen patent when it tried to change the product label for one of its drugs. 18 May 2015
Asia
The Supreme Court of India has ordered Glenmark Pharmaceuticals to stop making generic versions of Merck Sharp & Dohme’s diabetes drugs Januvia and Janumet. 18 May 2015
Americas
The University of Oxford has today launched a £300 million project aimed at enhancing the intellectual property of businesses active in the life sciences and medicinal sciences industries. 14 May 2015
Americas
The Foundation for AIDS Research has warned that the Trans-Pacific Partnership’s changes to IP policy could restrict access to affordable generic medicines in low and middle income countries. 13 May 2015
Big Pharma
The European Patent Office has revoked a patent covering biotechnology company Celgene’s cancer drug Revlimid. 12 May 2015
Asia
The Indian Patent Office has rejected Johnson & Johnson subsidiary Janssen Pharmaceutica’s application to patent its HIV drug Edurant, according to a report by The Financial Express. 12 May 2015
Americas
The Supreme Court of California has ruled that so-called “pay-for-delay” patent settlements can be challenged under state antitrust law in a case centering on Bayer’s antibiotic drug Cipro. 11 May 2015